This session provides an overview of the principles of safety reporting associated with marketed medicinal products including spontaneous reporting systems.

Have an account?

Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

Session 12: Postmarketing Safety Principles and Spontaneous Case Reporting

Session Chair(s)

Jill W. Buckley, PharmD

Be informed and stay engaged.